Befejeződött1. fázis
Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D
Key facts
- Where
- Neuss, NémetországSee the site
- Phase
- 1. fázis
Where in Németország
- PROFIL Institut fuer Stoffwechselforschung GmbHNeuss, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nanexa AB
- Trial code
- EU 2023-508054-25-01
- Record updated
- 2025. január 24.